BSEM
BioStem Technologies, Inc. Common Stock (BSEM)
Healthcare • NASDAQ • $1.49-28.50%
- Symbol
- BSEM
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $1.49
- Daily Change
- -28.50%
- Market Cap
- $39.02M
- Trailing P/E
- 2.38
- Forward P/E
- 7.21
- 52W High
- $8.40
- 52W Low
- $1.88
- Analyst Target
- $7.00
- Dividend Yield
- 0.00%
- Beta
- 0.50
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in A…
Company websiteResearch BSEM on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.